Rainbow Biosciences, LLC (RBCC) Keeping Pace with Broader 3D Bioprinting Industry
Rainbow Biosciences, a wholly owned subsidiary of Rainbow Coral Corp., is working to market and develop an innovative new 3D bioprinting system, leveraging momentum in the broader bioprinting industry. New 3D printing innovations reveal increasing numbers of applications to the medical field, generating massive demand for the 3D printing technology from patients and doctors. A British surgeon recently used the latest 3D printing techniques to create a new pelvis for a man who had lost half of his own to bone cancer. The groundbreaking transplant was the first of its kind, but only one of numerous medical breakthroughs and applications…